Clinical trial · Interventional
Feasibility of Ultra-sound Guided Radiofrequency Ablation in the Management of Head and Neck Neoplasia.
NCT00381225CI-TRIAL-00029456withdrawnN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Administratively withdrawn by the IRB prior to IRB approval
Summary
Brief summary (as posted)
To study the feasibility of Radiofrequency ablation (RFA) via ultrasound guidance in the management of head and neck neoplasia.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Neoplasia | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ultra-sound guided radio-frequency ablation | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Ultra-sound guided radio-frequency ablation
- interventionNames
- Procedure: Ultra-sound guided radio-frequency ablation
Primary outcomes (1)
- measure
- Technical success
- timeFrame
- Length of the procedure, up to 1 hour
- description
- Technical success is defined as the ability to successfully enter the thyroid nodule via ultrasound guidance and apply the RFA. Assessed via surgeon self report
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with head and neck neoplasia. Exclusion Criteria: * When the patient does not meet the inclusion criteria. * When the patient has a contra-indication of surgery or anesthesia. * If the patient refuses involvement in the study.
References
Publications (0)
Data not yet available
No reference posted for this study.